Calton & Associates Inc. Reduces Stake in The Procter & Gamble Company (NYSE:PG)

Calton & Associates Inc. lowered its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 3.8% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 2,547 shares of the company’s stock after selling 100 shares during the quarter. Calton & Associates Inc.’s holdings in Procter & Gamble were worth $420,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. HighPoint Advisor Group LLC acquired a new position in Procter & Gamble in the fourth quarter valued at $17,696,000. Campbell Wealth Management raised its stake in Procter & Gamble by 13.1% during the 4th quarter. Campbell Wealth Management now owns 1,988 shares of the company’s stock valued at $291,000 after acquiring an additional 231 shares during the last quarter. Herold Advisors Inc. lifted its position in Procter & Gamble by 2.2% during the 4th quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock worth $3,897,000 after acquiring an additional 581 shares during the period. V Square Quantitative Management LLC grew its stake in shares of Procter & Gamble by 29.0% in the 1st quarter. V Square Quantitative Management LLC now owns 43,202 shares of the company’s stock valued at $7,010,000 after purchasing an additional 9,716 shares during the last quarter. Finally, Metis Global Partners LLC increased its holdings in shares of Procter & Gamble by 15.7% in the fourth quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after purchasing an additional 15,599 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 0.0 %

Shares of PG traded down $0.03 during mid-day trading on Friday, reaching $167.89. The company had a trading volume of 5,640,925 shares, compared to its average volume of 7,681,546. The stock has a market cap of $396.24 billion, a price-to-earnings ratio of 27.43, a price-to-earnings-growth ratio of 3.66 and a beta of 0.41. The firm has a fifty day simple moving average of $166.99 and a 200-day simple moving average of $163.26. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $171.72. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The company had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. Procter & Gamble’s revenue for the quarter was down .1% on a year-over-year basis. During the same quarter last year, the business earned $1.37 EPS. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, July 19th. This represents a $4.03 annualized dividend and a dividend yield of 2.40%. Procter & Gamble’s payout ratio is 65.85%.

Insider Buying and Selling

In related news, CEO Sundar G. Raman sold 31,924 shares of Procter & Gamble stock in a transaction on Monday, May 20th. The shares were sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the sale, the chief executive officer now owns 19,042 shares of the company’s stock, valued at approximately $3,179,061.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Sundar G. Raman sold 31,924 shares of Procter & Gamble stock in a transaction on Monday, May 20th. The shares were sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the sale, the chief executive officer now owns 19,042 shares of the company’s stock, valued at approximately $3,179,061.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The disclosure for this sale can be found here. Insiders have sold 116,313 shares of company stock valued at $19,703,643 in the last quarter. Company insiders own 0.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Citigroup increased their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft lifted their price target on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Royal Bank of Canada increased their price objective on Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 31st. Barclays decreased their target price on shares of Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating on the stock in a research report on Thursday, August 1st. Finally, Evercore ISI increased their price target on shares of Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a report on Thursday, July 18th. Nine investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $173.95.

Check Out Our Latest Stock Analysis on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.